Acusphere Announces Results of FDA Advisory Committee Meeting (Bu...

Thu, 11 Dec 2008 01:00:00 GMT

Acusphere Announces Results of FDA Advisory Committee Meeting. - WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ: ACUS - News) today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S.

FDA panel rejects Acusphere heart imaging agent

Wed, 10 Dec 2008 22:57:51 GMT

SILVER SPRING, Maryland (Reuters) - A U.S. Food and Drug Administration advisory panel rejected Acusphere Inc's imaging contrast agent on Wednesday, saying possible risks outweighed its potential for screening

Merck Yesterday, Lilly Tomorrow (at CNBC)

Wed, 10 Dec 2008 16:25:35 GMT

Analysts have a one-day respite between two major pharma R & D days and they're using it to size up Merck's update yesterday and to set expectations for Eli Lilly's briefing tomorrow.

Acusphere raises $20M (at bizjournals.com)

Mon, 03 Nov 2008 21:35:13 GMT

The Watertown, Mass.-based company (Nasdaq: ACUS) said on Monday that Cephalon Inc. (Nasdaq: CEPH) of Frazer, Penn., will invest $20 million — $5 million in cash and another $15 million through a senior secured convertible note.

Biotech Update: Arena Pharmaceuticals, Acusphere, Cephalon, ViroP...

Mon, 03 Nov 2008 13:16:16 GMT

Though we’re anywhere but in a high growth market presently, there are groups that may provide big upsides based on growth potential, especially in light of major recent pull-backs.

Acusphere lays off 24 workers

Mon, 28 Jul 2008 18:57:09 GMT

Acusphere estimates the measures will save about $2.1 million. The goal is to decrease operating costs as the company waits for U.S. Food and Drug Administration approval of Imagify, its new imaging agent. Acusphere estimates the FDA will make a decision on Imagify, by Feb. 28, 2009.

Acusphere takes in $10M from microsphere license deal

Mon, 31 Mar 2008 14:38:16 GMT

Biotech firm Acusphere Inc. has licensed its drug-delivery technology for the treatment of cancer to biopharmaceutical company Cephalon Inc. for $10 million cash, according to executives. Acusphere (Nasdaq: ACUS) said the license to Cephalon, which is based in Frazer, Pa.

Pharmacy Choice - Pharmaceutical News - Acusphere Receives Comple...

TEWKSBURY, Mass.--(BUSINESS WIRE)--March 11, 2009--Acusphere, Inc. announced today that it has received a complete response from the U.S. Food & Drug Administration (FDA).

Acusphere Amends Terms Of License Agreement With Cephalon

Wed, 24 Jun 2009 00:00:00 GMT

Acusphere has cancelled Cephalon's $15 million Senior Secured Convertible Note. It has amended March and November 2008 License Agreements with Cephalon, for the oncology applications of Acusphere's Hydrophobic Drug Delivery System technology, and AI-525, an intravenous formulation of celecoxib.

US FDA Panel Rejects Acusphere Inc. Heart Imaging Agent

Thu, 11 Dec 2008 12:00:00 GMT

WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ: ACUS - News) today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration advised that the diagnostic benefit of contrast enhancement using Acuspheres ImagifyTM (Perflubutane Polymer

FDA panel pans Acusphere heart-imaging drug (AP)

Wed, 10 Dec 2008 21:48:14 GMT

FDA panel pans Acusphere heart-imaging drug. - WASHINGTON (AP) -- Federal advisers said Wednesday the risks of an imaging drug made by Acusphere, including abnormally low blood pressure, outweigh any advantages it has over older products.

Acusphere Inc. Stock Trading Halted Today; FDA Advisory Committee...

Wed, 10 Dec 2008 12:00:00 GMT

WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ: ACUS - News) today announced that NASDAQ has halted trading in the Companys common stock today. The Cardio Renal Advisory Committee to the U.S. Food & Drug Administration is meeting, in a public session, to review Acuspheres lead product

Medivation Inc. Q3 2008 Earnings Call Transcript

Tue, 11 Nov 2008 05:21:14 GMT

Medivation Inc. (MDVN)Q3 2008 Earnings CallComplete Story

Acusphere Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha...

Mon, 10 Nov 2008 23:51:09 GMT

Welcome to the third quarter Acusphere earnings conference call. (Operator Instructions) I would now like to turn the presentation over to Mary Conway, Investor Relations. Mary Conway Good afternoon and thank you for joining us for Acusphere’s Q3 ’08 investor conference call.

Noteworthy Developments in Biotech (Zacks.com)

Mon, 03 Nov 2008 06:00:00 GMT

Noteworthy Developments in Biotech. - Though we're anywhere but in a high growth market presently, there are groups that may provide big upsides based on growth potential, especially in light of major recent pull-backs.

Acusphere Inc. Announces Signing of a Definitive Agreement with C...

Mon, 27 Oct 2008 12:00:00 GMT

WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ:ACUS - News) today announced the signing of a definitive agreement with Cephalon, Inc. to provide $20 million in upfront financing by purchasing a $15 million senior secured convertible note and by paying a $5 million upfront fee for an

Acusphere, Inc. Announces Posting of Briefing Documents for FDA C...

Mon, 08 Dec 2008 15:05:00 GMT

Acusphere, Inc. Announces Posting of Briefing Documents for FDA Cardio Renal Drugs Advisory Committee Meeting on Imagify. - WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ: ACUS - News) today announced that the U.S.

Acusphere Inc. Q3 2008 Earnings Call Transcript

Mon, 10 Nov 2008 23:51:09 GMT

Acusphere Inc. (ACUS)Q3 2008 Earnings CallComplete Story

Acusphere, Inc. Reports Q3 2008 Financial Results and Business Hi...

Mon, 10 Nov 2008 14:00:00 GMT

Acusphere, Inc. Reports Q3 2008 Financial Results and Business Highlights. - WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ: ACUS - News) today reported financial results for the third quarter ended September 30, 2008 and commented on its financial results and business highlights.

Arena Pharmaceuticals Announces Third Quarter 2008 Financial Resu...

Thu, 30 Oct 2008 20:03:00 GMT

Arena Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2008.

Acusphere Announces the Transfer of its Listing of Common Stock f...

Tue, 28 Oct 2008 20:01:00 GMT

Acusphere Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market. - WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ:ACUS - News) today announced that the Nasdaq Hearings Panel has approved its request to transfer its common stock

Zibb.com: Acusphere, Incorporated (Industry News & Blogs)

Cadence Reports Priority Review, Acceptance Of NDA Submission For...

Acusphere Inc. Announces Amended Terms of Cephalon, Inc. Agreemen...

Acusphere Opts for $1M in Immediate Cash over $15M Milestone Fees...

FDA Calendar Updates: Acusphere, AspenBio, Alkermes